Therapeutic Potential of Ghrelin in the Treatment of Heart Failure

This publication has 79 references indexed in Scilit:

• Loss of G_q/11 Family G Proteins in the Nervous System Causes Pituitary Somatotroph Hypoplasia and Dwarfism in Mice
  Molecular and Cellular Biology, 2005
• Effects of Ghrelin Administration on Left Ventricular Function, Exercise Capacity, and Muscle Wasting in Patients With Chronic Heart Failure
  Circulation, 2004
• Ghrelin Acts at the Nucleus of the Solitary Tract to Decrease Arterial Pressure in Rats
  Hypertension, 2004
• A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
  New England Journal of Medicine, 2001
• Ghrelin Acts in the Central Nervous System to Stimulate Gastric Acid Secretion
  Biochemical and Biophysical Research Communications, 2001
• Ghrelin and Des-acyl Ghrelin: Two Major Forms of Rat Ghrelin Peptide in Gastrointestinal Tissue
  Biochemical and Biophysical Research Communications, 2000
• Role of Growth Hormone in Chronic Heart Failure
  Drugs, 2000
• The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
  New England Journal of Medicine, 1996
• A Clinical Trial of the Angiotensin-Converting–Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial Infarction
  New England Journal of Medicine, 1995
• GH-releasing activity of hexarelin, a new growth hormone releasing peptide, in infant and adult rats
  Life Sciences, 1994